The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis

Liang, Xiangwen; Xie, Wenchao; Lin, Zhihai; Liu, Ming

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

27/12Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all

The Anatolian Journal of Cardiology

The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis [Anatol J Cardiol]

Anatol J Cardiol. 2021; 25(2): 77-88 | DOI: 10.14744/AnatolJCardiol.2020.18049

The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis

Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming Liu
Department of Cardiology, the First People’s Hospital of Yulin, the Sixth Affiliated Hospital of Guangxi Medical University; Guangxi-China

Keywords: edoxaban, warfarin, atrial fibrillation, meta-analysis

Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming Liu. The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis. Anatol J Cardiol. 2021; 25(2): 77-88

Corresponding Author: Ming Liu, China
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all